PROGNOSTIC VALUE OF PET-DERIVED PARAMETERS (SUVMAX AND ΔSUV) IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH CAR-T CELL THERAPY: A SINGLE-CENTER RETROSPECTIVE ANALYSIS (SIE 2026) - Oct 6, 2026 - Abstract #SP064; "Data from 53 LBCL patients treated with axi-cel or tisa-cel at Sapienza University Center (Nov 2019–Nov 2024) were analyzed. J Nucl Med.2025; 66(2):209-214Itti et al. JNuclMed.2023; 64(11):1706-1711"
CAR T-Cell Therapy • IO biomarker • Retrospective data • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Primary Mediastinal Large B-Cell Lymphoma • Tic Disorders
|
|
L. Donzelli1; C. Mancino1; S. Puglia2; A. Boria1; L. Petrucci1; M. Ansuinelli1; O. Bagni3; M. Martelli1; A. Di Rocco1
|